Skip to content

Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock

Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock - Randomized, Controlled and Double-blind Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03754257
Enrollment
36
Registered
2018-11-27
Start date
2018-10-01
Completion date
2024-10-21
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Shock, SIRS

Keywords

sepsis, septic shock, electrical stimulation

Brief summary

Background: Electrical stimulation has been used in critical patients as an adjunct strategy of early rehabilitation. In septic or septic shock patients there are reports of only two studies in the literature, with conflicting results. Objective: To evaluate the effects of electrical stimulation in the prevention of muscle mass loss in patients admitted to the ICU with systemic inflammatory response syndrome (SIRS), sepsis or septic shock. Methods: This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group. They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers. Expected results: Electrical stimulation is expected to be able to prevent loss of muscle mass in patients admitted to the ICU with SIRS, sepsis or septic shock. In addition, it is expected to be able to preserve strength in this population without increasing the pro-inflammatory or metabolic response.

Detailed description

This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group.They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers.

Interventions

PROCEDUREExperimental Electrical Stimulation

Experimental Electrical Stimulation (100Hz) during 40 minutes

Sham Electrical Stimulation (5Hz) during 40 minutes

OTHERConventional Physiotherapy

Active and passive exercises, and walking.

Sponsors

Hospital Sirio-Libanes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients admitted to the ICU with a diagnosis of SIRS, sepsis or septic shock, * aged ≥ 18 years, * body mass index (BMI) ≤ 35 kg / m2, * without diabetic polyneuropathy, * without cardiac pacemaker, * without diagnosis of neuromuscular diseases, * absence of skin lesions.

Exclusion criteria

* heart attack, * death.

Design outcomes

Primary

MeasureTime frameDescription
Muscle mass8 daysCross-sectional area

Secondary

MeasureTime frameDescription
Peripheral muscle strength8 daysMedical Research Council Scale will be used to measure the peripheral muscle strength. The patient's effort is graded on a scale of 0-5: Grade 5: Muscle contracts normally against full resistance. Grade 4: Muscle strength is reduced but muscle contraction can still move joint against resistance. Grade 3: Muscle strength is further reduced such that the joint can be moved only against gravity with the examiner's resistance completely removed. As an example, the elbow can be moved from full extension to full flexion starting with the arm hanging down at the side. Grade 2: Muscle can move only if the resistance of gravity is removed. As an example, the elbow can be fully flexed only if the arm is maintained in a horizontal plane. Grade 1: Only a trace or flicker of movement is seen or felt in the muscle or fasciculations are observed in the muscle. Grade 0: No movement is observed. The total score ranges from 0 (complete tetraparesis) to 60 points (normal muscle strength).
Functional status8 daysFunctional status will be assessed using the Surgical Intensive Care Unit Optimal Mobilization Score. This score classifies mobility from 0 to 4: The SOMS 0 - No mobility indicates that no mobilization should be considered due to the patients' clinical status. SOMS 1 - Passive mobilization indicates that passive mobilization can be carried out in bed. SOMS 2 - Sitting demonstrates that the patient is already able to sit on the bed or in a chair. SOMS 3 - Standing, indicates that the patient can perform orthostatism, with or without assistance. The highest level of SOMS 4 - Ambulation, shows that the patient is capable of ambulation.
Inflammatory5 daysIL-1α
Metabolic, damage and muscular trophism markers5 daysLactate

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026